HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of patients with supraventricular tachyarrhythmias in a medical intensive care unit.

Abstract
Direct-current cardioversion has a higher success rate than does medical therapy in converting supraventricular tachyarrhythmias to sinus rhythm and should be performed immediately in patients with hemodynamic instability. Hemodynamically stable patients with atrial fibrillation or atrial flutter, a rapid ventricular rate and without preexcitation syndrome should be treated with intravenous beta-adrenergic blocking drugs, amiodarone, verapamil, or diltiazem. In hemodynamically unstable patients with supraventricular tachycardia, intravenous adenosine is the drug of choice.
AuthorsArunabh Sekhri, Wilbert S Aronow, Vishal Sekhri, Chandrasekar Palaniswamy, Dipak Chandy
JournalComprehensive therapy (Compr Ther) 2009 Fall-Winter Vol. 35 Issue 3-4 Pg. 188-91 ISSN: 0098-8243 [Print] United States
PMID20043615 (Publication Type: Journal Article)
Chemical References
  • Cardiovascular Agents
Topics
  • Aged
  • Aged, 80 and over
  • Cardiovascular Agents (administration & dosage)
  • Electric Countershock
  • Female
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • Prospective Studies
  • Tachycardia, Supraventricular (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: